Indication

Recurrent Vulvovaginal Candidiasis

Recurrent vulvovaginal candidiasis is a chronic, relapsing fungal infection of the lower female genital tract, typically defined as experiencing three or more symptomatic episodes within a twelve-month period. Read more about Recurrent Vulvovaginal Candidiasis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Recurrent Vulvovaginal Candidiasis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Recurrent Vulvovaginal Candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Recurrent Vulvovaginal Candidiasis.

Recurrent vulvovaginal candidiasis is a chronic, relapsing fungal infection of the lower female genital tract, typically defined as experiencing three or more symptomatic episodes within a twelve-month period.

Primarily affecting women of reproductive age, it is predominantly caused by *Candida albicans*, although non-*albicans* species such as *Candida glabrata* may also be implicated.

Pathophysiologically, the condition involves an aggressive, dysregulated local mucosal immune and inflammatory response to yeast colonization rather than systemic immune deficiency.

Patients typically present with recurrent episodes of intense vulvar pruritus, burning, soreness, dyspareunia, external dysuria, erythema, edema, and characteristic thick, white vaginal discharge.

Personalize your experience

Follow Recurrent Vulvovaginal Candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it